- Rank in Search Criteria: 5731
World Rank (Jan-05-2024): 19,569
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19923
Market Cap (Jul-30-2023): 0.14 Billion USD
World Rank (Jan-2022): 22,352
Market Cap (Jan-2022): 0.11 Billion USDHeadquarters Country: USA Annual Revenue in USD: 22 Million USD
Annual Net Income in USD: 3 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5732
World Rank (Jan-05-2024): 19,571
World Rank (Jul-30-2023): 19571
World Rank (Jan-2022): 19,571
Market Cap (Jan-2022): 0.18 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 5733
World Rank (Jan-05-2024): 19,575
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 20558
Market Cap (Jul-30-2023): 0.12 Billion USD
World Rank (Jan-2022): 25,536
Market Cap (Jan-2022): 0.06 Billion USD
- Rank in Search Criteria: 5734
World Rank (Jan-05-2024): 19,576
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 17505
Market Cap (Jul-30-2023): 0.22 Billion USD
World Rank (Jan-2022): 22,669
Headquarters Country: USA Company Profile: Nuvectis Pharma is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. The headquarters is in United States.
- Rank in Search Criteria: 5735
World Rank (Jan-05-2024): 19,577
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19259
Market Cap (Jul-30-2023): 0.16 Billion USD
World Rank (Jan-2022): 17,936
Market Cap (Jan-2022): 0.24 Billion USDHeadquarters Country: USA Annual Revenue in USD: 99 Million USD
Annual Net Income in USD: 97 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5736
World Rank (Jan-05-2024): 19,578
World Rank (Jul-30-2023): 19578
Market Cap (Jul-30-2023): 0.15 Billion USD
World Rank (Jan-2022): 19,622
Market Cap (Jan-2022): 0.18 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 5737
World Rank (Jan-05-2024): 19,588
Market Cap (Jan-05-2024): 0.14 Billion USD
World Rank (Jul-30-2023): 21426
Market Cap (Jul-30-2023): 0.11 Billion USD
World Rank (Jan-2022): 20,984
Market Cap (Jan-2022): 0.14 Billion USDHeadquarters Country: USA Annual Revenue in USD: 677 Million USD
Annual Net Income in USD: 153 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5738
World Rank (Jan-05-2024): 19,590
Market Cap (Jan-05-2024): 0.14 Billion USD
World Rank (Jul-30-2023): 20960
Market Cap (Jul-30-2023): 0.11 Billion USD
World Rank (Jan-2022): 19,994
Market Cap (Jan-2022): 0.17 Billion USDHeadquarters Country: USA Annual Revenue in USD: 240 Million USD
Annual Net Income in USD: 5 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 5739
World Rank (Jan-05-2024): 19,593
World Rank (Jul-30-2023): 19593
Market Cap (Jul-30-2023): 0.15 Billion USD
World Rank (Jan-2022): 13,486
Market Cap (Jan-2022): 0.50 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: -1 Million USD
Annual Results for Period ending: Dec-2021 ending yearCompany Profile: M3-Brigade Acquisition II Corp. is a Traditional Investment company. The headquarters is in USA.
- Rank in Search Criteria: 5740
World Rank (Jan-05-2024): 19,604
Market Cap (Jan-05-2024): 0.14 Billion USD
World Rank (Jul-30-2023): 19541
Market Cap (Jul-30-2023): 0.15 Billion USD
World Rank (Jan-2022): 19,729
Market Cap (Jan-2022): 0.18 Billion USD